Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record.

Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators

Al‐Refaie, F. N., Hershko, C., Hoffbrand, A. V., Kosaryan, M., Olivieri, N. F., Tondury, P., Wonke, B. · 1995 · British Journal of Haematology

Abstract

Summary This report updates the combined experience of four centres involved in the long‐term treatment of transfusional iron overload in 84 patients with the oral iron chelator deferiprone (L1) over 167 patient‐years. The source of L1 was variable, including two university research laboratories and three pharmaceutical firms. Compliance was rated as excellent in 48%, intermediate in 36%, and poor in 16% of patients. On a mean L1 dose of 73–81 mg/kg/d, urinary iron excretion was stable, at around 0 5 mg/kg/d, with no indication of a diminishing response with time. Serum ferritin showed a very steady decrease with time from an initial mean ±1SD of 4207 ±3118 to 1779 ± 1154μg/1 after 48 months (P< 0–001). 17 patients abandoned L1 therapy, Major complications of L1 requiring permanent discontinuation of treatment included agranulocytosis (three), severe nausea (four), arthritis (two) and persistent liver dysfunction (one). The remaining patients abandoned treatment because of low compliance (three) and conditions unrelated to L1 toxicity (four). Lesser complications permitting continued L1 treatment included transient mild neutropenia (four), zinc deficiency (12), transient increase in liver enzymes (37), moderate nausea (three) and arthropathy (17). There was no treatment‐related mortality. Although the complications associated with L1 treatment are significant and require close monitoring, they do not preclude effective long‐term therapy in the vast majority of patients. Further well‐controlled prospective studies of L1 are required in order to enable proper judgement of its suitability for general long‐term clinical use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.1995.tb05274.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 164

Metadata

Authors
Al‐Refaie, F. N., Hershko, C., Hoffbrand, A. V., Kosaryan, M., Olivieri, N. F., Tondury, P., & Wonke, B.
Venue
British Journal of Haematology
Publisher
Wiley
Published
1995-09
Volume
91
Issue
1
Pages
224-229
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2132319098
Cited by
164
References
0
FWCI
4.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators. https://app.cochat.ai/papers/10.1111/j.1365-2141.1995.tb05274.x
The paper
Al‐Refaie, F. N., Hershko, C., Hoffbrand, A. V., Kosaryan, M., Olivieri, N. F., Tondury, P., & Wonke, B. (1995). Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1995.tb05274.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.